Danshen Dropping Pill for Coronary Heart Disease Heart and Artery Structure and Function

The Impact of Compound Danshen Dropping Pill for Coronary Heart Disease With Hypertension Patient Heart and Artery Structure and Function

Status

UNKNOWN

Phases

Phase 4

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT01825759

Enrollment

200

Registered

2013-04-08

Start date

2013-01-31

Completion date

2014-12-31

Last updated

2013-04-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Coronary Heart Disease, Essential Hypertension

Brief summary

The Impact of Compound danshen dropping pill for coronary heart disease (CHD) heart and artery structure and function in patients with hypertension

Detailed description

Compound danshen dropping pill for coronary heart disease (CHD) heart and artery structure and function in patients with hypertension.We can accorand the pwv ,IMT and MDA to assess the impact of heart and artery structure and function.

Interventions

DRUGdanshen dripping pill

Study design

Allocation

Intervention model

SINGLE_GROUP

Primary purpose

TREATMENT

Masking

NONE

Eligibility

Sex/Gender

ALL

Age

35 Years to 75 Years

Healthy volunteers

Yes

Inclusion criteria

coronary heart disease，primary hypertension， -

Exclusion criteria

secondary hypertension，diabetes mellitus，chronic renal disease，cardiac insufficiency \-

Design outcomes

Primary

Measure	Time frame
Pulse wave velocity	one year

Secondary

Measure	Time frame
ankle-brachial index	one year

Other

Measure	Time frame
intima-media thickness,methyl-di-aide-hyde	one year

Countries

China

Contacts

Primary Contactchen xi ping, master

panpei74@163.com028-85423352

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026